Compounds > clorazepate dipotassium
Page last updated: 2024-09-05

clorazepate dipotassium and fluphenazine

clorazepate dipotassium has been researched along with fluphenazine in 1 studies

Compound Research Comparison

Studies
(clorazepate dipotassium)		Trials
(clorazepate dipotassium)		Recent Studies (post-2010)
(clorazepate dipotassium)		Studies
(fluphenazine)		Trials
(fluphenazine)		Recent Studies (post-2010) (fluphenazine)
32590112,494400130

Protein Interaction Comparison

ProteinTaxonomyclorazepate dipotassium (IC50)fluphenazine (IC50)
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.067
Potassium channel subfamily K member 2Homo sapiens (human)4.7
Tyrosine-protein kinase FynHomo sapiens (human)7.99
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)1.962
Muscarinic acetylcholine receptor M2Homo sapiens (human)7.481
Muscarinic acetylcholine receptor M4Homo sapiens (human)3.468
ATP-dependent translocase ABCB1Homo sapiens (human)6.1
Alpha-2A adrenergic receptorHomo sapiens (human)0.215
Muscarinic acetylcholine receptor M1Homo sapiens (human)2.683
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)5.7058
D(2) dopamine receptorHomo sapiens (human)0.0016
Alpha-2B adrenergic receptorHomo sapiens (human)0.029
Alpha-2C adrenergic receptorHomo sapiens (human)0.154
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)1.644
Muscarinic acetylcholine receptor M3Homo sapiens (human)4.728
D(1A) dopamine receptorHomo sapiens (human)0.023
D(4) dopamine receptorHomo sapiens (human)5.877
Sodium-dependent noradrenaline transporter Homo sapiens (human)1.962
Histamine H2 receptorHomo sapiens (human)1.226
Alpha-1D adrenergic receptorHomo sapiens (human)0.033
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.0051
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.067
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)1.644
Sodium-dependent serotonin transporterHomo sapiens (human)1.492
Melanocortin receptor 5Homo sapiens (human)9.518
Pleiotropic ABC efflux transporter of multiple drugsSaccharomyces cerevisiae S288C1.7
Histamine H1 receptorHomo sapiens (human)0.04
D(3) dopamine receptorHomo sapiens (human)0.0006
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.039
5-hydroxytryptamine receptor 6Homo sapiens (human)0.052
Sodium-dependent dopamine transporter Homo sapiens (human)2.053
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)5.7058
Nuclear receptor subfamily 3 group C member 3 Bos taurus (cattle)5.7058
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodie, NH; Dunckley, HG; McGhie, RL; O'Hara, H; O'Hara, J; Schiff, AA1

Trials

1 trial(s) available for clorazepate dipotassium and fluphenazine

ArticleYear
Anxiety states in family practice: an evaluation of the need for antidepressant as well as anxiolytic therapy.
    The Journal of international medical research, 1977, Volume: 5, Issue:5

    Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Clinical Trials as Topic; Clorazepate Dipotassium; Drug Therapy, Combination; Family Practice; Female; Fluphenazine; Humans; Male; Middle Aged; Nortriptyline

1977